Streptococcus pyogenes Rosenbach (ATCC® BAA-947)

Strain Designations: MGAS 5005  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations MGAS 5005
Application
Emerging infectious disease research
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Type Strain no
Biosafety Level 2
Antigenic Properties Serotype M1
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Streptococcus pyogenes MGAS5005, complete genome.

Type Strain no
Antigenic Properties Serotype M1
Comments
Genome sequenced strain
Name of Depositor JM Musser, D Low
Special Collection ATCC
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Year of Origin 1996
References

Virtaneva K, et al. Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect. Immun. 71: 2199-2207, 2003. PubMed: 12654842

James M Musser, personal communication

Cross References

Nucleotide (GenBank) : CP000017 Streptococcus pyogenes MGAS5005, complete genome.